Take Melatonin Every Night? A New Study Warns Of This Surprising Risk

Why It Matters

If confirmed, the link between chronic melatonin supplementation and serious cardiovascular outcomes could reshape prescribing practices and consumer habits in the multi‑billion‑dollar sleep‑aid market.

Key Takeaways

• Long‑term melatonin linked to 90% higher heart‑failure risk
• Hospitalizations for heart failure three times higher among melatonin users
• All‑cause mortality nearly doubled for chronic melatonin users
• Study analyzed 130,000 insomnia patients over five years
• Experts recommend sleep hygiene and magnesium over nightly melatonin

Pulse Analysis

Melatonin has become a staple on pharmacy shelves, marketed as a natural, low‑risk solution for insomnia and jet lag. Yet its regulatory status varies: in many countries it requires a prescription, while in the United States it is sold over the counter. The new five‑year cohort study, encompassing more than 130,000 diagnosed insomniacs, revealed a striking association between sustained melatonin intake and elevated cardiovascular events. By comparing prescription‑recorded users to non‑users, researchers observed a near‑doubling of all‑cause mortality and a 90% rise in heart‑failure incidence, prompting health‑care providers to reassess the safety profile of long‑term use.

Understanding why melatonin might influence heart health is complex. Chronic insomnia itself is an established risk factor for hypertension, arrhythmias, and heart failure, making it difficult to untangle cause from correlation. Moreover, the study’s reliance on prescription data may have excluded many U.S. consumers who purchase melatonin without a doctor’s order, potentially diluting the observed effect. Some clinicians speculate that melatonin could disrupt circadian regulation of blood pressure or interact with cardiovascular medications, but definitive mechanistic evidence remains lacking. Consequently, the medical community is calling for randomized controlled trials to verify these observational findings before issuing formal guidelines.

In the meantime, experts recommend prioritizing non‑pharmacologic sleep strategies. Maintaining a dark, cool bedroom, limiting evening caffeine and alcohol, and reducing screen exposure can markedly improve sleep quality. For those seeking a supplement, magnesium—known to support GABA activity and muscle relaxation—offers a safer alternative with minimal cardiovascular risk. Clinicians should counsel patients to reserve melatonin for short‑term scenarios, such as occasional jet lag, while monitoring any long‑term users for emerging cardiac symptoms. This nuanced approach balances the demand for effective sleep aids with the imperative to protect heart health.